20 (AIDX) Equity Average (2025 - 2026)
20 posted quarterly Equity Average of $1.3 million for Q1 2026, down 1.35% year-on-year from $1.3 million in Q1 2025, and up 142.77% on a QoQ basis from $521834.0 in Q4 2025.
20 (AIDX) has 2 years of Equity Average data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 1.35% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 1.35% YoY), and the FY2025 full-year result was $743128.5, changed N/A from the prior year.
- Equity Average for Q1 2026 stood at $1.3 million, up from $521834.0 in the prior quarter.
- Across five years, Equity Average topped out at $1.3 million in Q1 2025 and bottomed at $521834.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | 20 | - | - | 62,884.00 | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 743,128.50 |